This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Transcept Pharmaceuticals Inc (TSPT)

NASDAQ: Health Care

Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Assets
Cash and Equivalents 9.94M 39.37M 10.66M 13.72M
Receivables 0.00 0.00 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00 0.00
Total Current Assets 73.63M 94.97M 65.84M 69.42M
Property, Plant & Equipment, Gross 1.94M 2.59M 2.58M 2.64M
Accumulated Depreciation & Depletion 1.90M 2.46M 2.27M 2.02M
Property, Plant & Equipment, Net 43.00K 128.00K 314.00K 614.00K
Intangibles 0.00 0.00 0.00 0.00
Other Non-Current Assets 0.00 0.00 38.00K 808.00K
Total Non-Current Assets 43.00K 3.09M 3.31M 4.38M
Liabilities & Shareholder Equity
Total Assets 73.67M 98.06M 69.15M 73.81M
Accounts Payable 413.00K 1.00M 987.00K 598.00K
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 0.00 23.00K 244.00K 365.00K
Total Current Liabilities 1.93M 2.66M 3.34M 9.65M
Long Term Debt 0.00 0.00 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00 0.00
Other Non-Current Liabilities 0.00 0.00 60.00K 348.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 0.00 0.00 60.00K 348.00K
Total Liabilities 1.93M 2.66M 3.40M 10.00M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 71.74M 95.39M 65.75M 63.81M
Common Par 19.00K 19.00K 14.00K 13.00K
Additional Paid In Capital 211.26M 207.48M 165.80M 160.01M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -139.56M -112.11M -100.09M -96.21M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments 22.00K 7.00K 29.00K 2.00K
Total Capitalization 71.74M 95.39M 65.75M 63.81M
Total Equity 71.74M 95.39M 65.75M 63.81M
Total Liabilities & Stock Equity 73.67M 98.06M 69.15M 73.81M
Total Common Shares Outstanding 18.84M 18.68M 13.90M 13.45M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 18.77M 17.05M 13.53M 13.42M
Diluted Weighted Shares Outstanding 18.77M 17.05M 13.53M 13.42M
Number of Employees 8 15 17 31
Number of Part-Time Employees 0 0 0 0
TSPT News

TSPT Transcept Pharmaceuticals Inc

Analysts Ratings for TSPT

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET TSPT ANALYST REPORT

Brokerage Partners

TSPT Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs